Description
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
Product Unit Size | Cost | Quantity | Stock |
---|
This fibrinogen binding peptide has a sequence of EHIPA; it mimic the fibrinogen binding domain of GP IIb/IIIa, preventing fibrinogen-platelet binding; it may exhibit antithrombotic activity.
Purity | ≥98% |
---|---|
Formula | C25H39H7O8 |
Formula Wt. | 565.63 |
Synonym | EHIPA. |
Solubility | Soluble in water (2 mg/mL). |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Gartner TK, Loudon R, Taylor DB. The peptides APLHK, EHIPA and GAPL are hydropathically equivalent peptide mimics of a fibrinogen binding domain of glycoprotein IIb/IIIa. Biochem Biophys Res Commun. 1991 Nov 14;180(3):1446-52. PMID: 1953789.
Diketopiperazine produced by Aspergillus; micro...
Wnt/β-catenin inhibitor
Recombinant protein containing Treponema pallid...
Aureothricin is a member of the dithiolopyrrolo...
FIASMA; α1- and β1/2-adrenergic antagonist.
NSAID; COX-1/2 inhibitor.
Mycotoxin produced by Aspergillus; actin polyme...
Selective CDK2 inhibitor.
Antifungal antibiotic
Macrocyclic lactone.
MET, VEGFR2, Ron, Axl, FLT3 inhibitor.
Abl inhibitor.
Endogenous peptide hormone inolved in gastric e...
Semi-synthetic avermectin; GABA potentiator.
GHB/GABA analog found in Valeriana officinalis;...
HDAC inhibitor, mammalian RNA splicing modulato...
FIASMA, μOR agonist, potential HCN channel blo...
Endogenous cardiomodulatory peptide; NPR-A agon...
ALK and IGF-1R inhibitor.
Synthetic cafestol derivative.